EMA backs three orphan drugs
28
Mar
FDA approves Merck’s avelumab in MCC
BIO-Europe Spring: Southern growth ambitions
Toxoplasmosis: novel target to prevent transmission
Pulmocide raises £25m in Series B round
Something as silly has chicken pox has changed the life what it is. Something as silly has chicken pox has
NSCLC: Transgene launches cancer combo tests
Allogenic stem cell transplant safe in heart infarction patients